Here's Why Your First Social Security Check of the Year May Have Been Smaller Than Expected

Social Security recipients received a 2.8% COLA in January 2026, but many saw much of that boost offset by a $17.90 increase in Medicare Part B premiums which are deducted from monthly benefits. While the hold‑harmless provision prevents nominal year‑over‑year benefit cuts (e.g., a $2,000 benefit cannot drop below $2,000), rising Medicare costs can substantially erode COLA gains, creating an ongoing income risk for retirees and underscoring the need for non‑Social Security retirement income sources.

Analysis

Market structure: Rising Medicare Part B premiums that erode Social Security COLAs create a predictable shift in demand from fee-for-service Medicare into privately administered solutions (Medicare Advantage, Medigap, annuities). Direct winners are large MA roll-up insurers (UNH, HUM, CVS/Aetna) and annuity writers able to market guaranteed income; losers are discretionary retailers and service providers with high 65+ exposure whose real disposable income will compress. Pricing power favors scale players that can spread fixed admin costs across growing MA membership; small regional insurers and brokerages face margin pressure.

Risk assessment: Tail risks include a legislative cap on supplemental plan commissions or a policy change to Part B underwriting that could blunt private-market growth; regulatory headlines could move stocks >15% intra-quarter. Near-term (0–3 months) impact centers on enrollment messaging and CMS premium announcements; medium-term (3–12 months) on MA share gain metrics; long-term (1–3 years) on structural rerouting of retiree spend. Hidden dependencies: A sustained series of Part B increases could materially raise annuity demand but also raise political pressure on insurers and brokers.

Trade implications: Tactical long exposure to UNH and HUM (6–12 month horizon) captures MA share tailwinds; purchase collar/call-spread strategies to cap downside while keeping upside into open-enrollment cycles. Hedge consumption risk by increasing high-quality fixed-income (TLT/AGG mix) by 1–3% of portfolio as a defensive buffer if senior spending pulls GDP growth below trend. Monitor CMS premium and MA enrollment prints as primary catalysts; negative surprise (MA growth <3% YoY or CMS policy probes) should trigger de-risking.

Contrarian angles: Consensus assumes small, incremental shifts; I view this as structurally compounding — each 1ppt annual MA share gain from dissatisfied beneficiaries amplifies insurers' free cash flow and EPS by mid-single digits annually. The market underprices regulatory tail risk but also underestimates revenue stickiness from annuity/Medigap cross-sells; short-term political noise may create buying windows for UNH/HUM on >10% pullbacks. Historical parallel: 2010–15 MA expansion shows durable enrollment stickiness once consumers switch, arguing for multi-quarter holds rather than intraday trades.

Key Decisions for Investors

• Establish a 2–3% portfolio long position split: 60% UNH, 40% HUM (or substitute CVS if valuation preferred) with a 6–12 month horizon to capture expected Medicare Advantage enrollment gains; trim if MA net membership growth <3% YoY or either name drops >15% on fundamentals.
• Buy 6–12 month bull-call spreads on UNH (e.g., buy 5% OTM call, sell 15% OTM call) sized to represent 0.5–1% portfolio risk to participate in upside into open enrollment while capping premium cost.
• Add 1–2% allocation to annuity/insurance writers (e.g., AIG, MET) as a tactical long for 12–24 months to benefit from higher demand for guaranteed income; exit if quarterly retirement product sales do not rise by ≥10% YoY within two quarters.
• Increase high-quality fixed-income hedge by 1–3% (TLT and IG corporate mix) to protect portfolio cash-flow if senior consumption weakens; reduce hedge once CPI-ex-Food/Energy stabilizes and CMS signals smaller Part B increases (<$10) for next year.
• Monitor CMS Part B premium announcement and MA enrollment data over the next 30–60 days as primary catalysts; if regulatory scrutiny (House/Senate hearings or CMS probes) surfaces, shift 50% of long exposure into options hedges within 5 trading days.